New regulations on compensation for injury and death in drug trials.
Indian J Med Ethics
;
2013 Apr-Jun ; 10 (2): 76-79
Article
in English
| IMSEAR
| ID: sea-153604
ABSTRACT
In 2005, the government amended Schedule Y of the Drugs and Cosmetics Act, 1940, and Rules, 1945, to liberalise the conduct of global drug trials in India. Proponents of this policy had asserted that we needed less, and not more, regulation, in order to expand the business of drug trials. Many from the medical profession, the bioethics community and civil society groups have been critical of this policy.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Wounds and Injuries
/
Humans
/
Clinical Trials as Topic
/
Civil Rights
/
Compensation and Redress
/
Research Subjects
/
Drug-Related Side Effects and Adverse Reactions
/
Homicide
/
Human Experimentation
/
India
Type of study:
Prognostic study
Country/Region as subject:
Asia
Language:
English
Journal:
Indian J Med Ethics
Journal subject:
Ethics
Year:
2013
Type:
Article
Similar
MEDLINE
...
LILACS
LIS